Cargando…
Improved Glycemic Control Following Transition to Tubeless Insulin Pump Therapy in Adults With Type 1 Diabetes
Continuous subcutaneous insulin infusion (CSII) treatment may improve long-term glycemic outcomes and enhance quality of life compared with a multiple daily injection (MDI) insulin regimen for people with type 1 diabetes. As the number of people treated with CSII via a tubeless insulin pump is incre...
Autores principales: | Mehta, Sanjeev N., Tinsley, Liane J., Kruger, Davida, Bode, Bruce, Layne, Jennifer E., Huyett, Lauren M., Dryga, Kate, Dumais, Bonnie, Ly, Trang T., Laffel, Lori M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839599/ https://www.ncbi.nlm.nih.gov/pubmed/33551556 http://dx.doi.org/10.2337/cd20-0022 |
Ejemplares similares
-
Glycemic Control and Factors Impacting Treatment Choice in Tubeless Insulin Pump Users: A Survey of the T1D Exchange Glu Online Community
por: Layne, Jennifer E., et al.
Publicado: (2019) -
Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age
por: Ly, Trang T., et al.
Publicado: (2018) -
Improvements in Glycemic Outcomes in 4738 Children, Adolescents, and Adults with Type 1 Diabetes Initiating a Tubeless Insulin Management System
por: Aleppo, Grazia, et al.
Publicado: (2023) -
The Use of Omnipod® 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes With Suboptimal Glycemic Management: From Injections to Closed-Loop Therapy
por: Bode, Bruce W, et al.
Publicado: (2021) -
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
por: Brown, Sue A., et al.
Publicado: (2021)